In active UC, upadacitinib induced and maintained remission.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36191310.
- Also identified by DOI 10.7326/J22-0073.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Danese S, Vermeire S, Zhou W, et al. <b>Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.</b> Lancet. 2022;399:2113-28. 35644166.
Medical subject headings
- Colitis, Ulcerative